Hemofiltration for neuroprotection in acute ischemic stroke: A prospective, pilot study

Abstract

Hemofiltration reduces blood levels of cytokines, glutamate, and other substances that increase the risk of stroke‐associated neurodegeneration. This study aimed to assess the safety and efficacy of hemofiltration in acute ischemic stroke patients.